Synthesis and biological evaluation of 1,3-diphenylprop-2-yn-1-ones as dual inhibitors of cyclooxygenases and lipoxygenases

被引:33
作者
Rao, PNP [1 ]
Chen, QH [1 ]
Knaus, EE [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/j.bmcl.2005.07.036
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
A new class of 1,3-diphenylprop-2-yn-1-ones possessing a P-MeSO2 COX-2 phamacophore on the C-3 phenyl ring was designed for evaluation as dual inhibitors of cyclooxygenase (COX) and lipoxygenase (LOX). Among the group of compounds evaluated, 1-(4-fluorophenyl)-3-(4-methanesulfonylphenyl)prop-2-yn-1-one (11j) exhibited excellent COX-2 inhibitory potency (COX-2 IC50 = 0.1 mu M) and selectivity (SI = 300), whereas 1-(4-eyanophenyl)-3-(4-methanesulfonylphenyl)prop-2-yn-1-one (11d) exhibited an optimal combination of COX and LOX inhibition (COX-2 IC50 = 1.0 mu M; COX-2 SI = 31.5; 5-LOX IC50 = 1 -0 mu M; 15-LOX IC50 = 3.2 mu M). (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4842 / 4845
页数:4
相关论文
共 17 条
[1]
The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: Results from a randomized, controlled trial [J].
Bias, P ;
Buchner, A ;
Klesser, B ;
Laufer, S .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (04) :611-618
[2]
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[4]
Adverse cardiovascular effects of the coxibs [J].
Dogné, JM ;
Supuran, CT ;
Pratico, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) :2251-2257
[5]
ANTIINFLAMMATORY EFFECTS OF VARIOUS DRUGS ON ACETIC-ACID INDUCED COLITIS IN THE RAT [J].
FITZPATRICK, LR ;
BOSTWICK, JS ;
RENZETTI, M ;
PENDLETON, RG ;
DECKTOR, DL .
AGENTS AND ACTIONS, 1990, 30 (3-4) :393-402
[6]
A mild, efficient and selective cleavage of aryl tert-butyldimethysilyl ethers using KOH in ethanol [J].
Jiang, ZY ;
Wang, YG .
CHEMISTRY LETTERS, 2003, 32 (07) :568-569
[7]
Marcouiller P, 2005, J RHEUMATOL, V32, P704
[8]
New COX-2/5-LOX inhibitors:: Apoptosis-inducing agents potentially useful in prostate cancer chemotherapy [J].
Pommery, N ;
Taverne, T ;
Telliez, A ;
Goossens, L ;
Charlier, C ;
Pommery, J ;
Goossens, JF ;
Houssin, R ;
Durant, F ;
Hénichart, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6195-6206
[9]
Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast [J].
Ramires, R ;
Caiaffa, MF ;
Tursi, A ;
Haeggström, JZ ;
Macchia, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (02) :815-821
[10]
Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors [J].
Rao, PNP ;
Uddin, MJ ;
Knaus, EE .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (16) :3972-3990